News | Ostoform

https://ostoform.com/wp-content/uploads/2025/02/ostoform-premier-press-realease-640x300-c-default.jpg

Ostoform awarded Enterostomal Therapy products agreement with Premier, Inc.

Ostoform has been awarded a Technology Breakthrough designation for FLOWASSIST with Premier, Inc.

Ostoform Receives Innovative Technology Contract from Vizient for FLOWASSIST

Ostoform announced its FLOWASSIST product range has been awarded an Innovative Technology contract by Vizient, Inc. the largest provider-driven healthcare…

Ostoform awarded €2.5 million in grant funding from the European Innovation Council (EIC) Accelerator Program

Ostoform Awarded €2.5M in Grant Funding from the European Innovation Council (EIC) Accelerator Program

20 October 2022, Ostoform is delighted to announce it has been awarded €2.5M in non-dilutive grant funding through the…

Ostoform Exhibiting at WOCNext® 2022

Ostoform is pleased to announce it will be exhibiting at this year’s WOCNext® conference, taking place in Fort Worth, Texas…

International MedTech veteran joins Ostoform board

4 April 2022, Ostoform has announced the appointment of Stephan Bonnelycke as a non-executive Director of the company. Stephan is…

Kevin Kelleher CEO of Ostoform holding a box of the Ostoform Seal outside BGF building

Ostoform Raises €3 million in Funding Round

Ostoform is pleased to announce that capital investor, BGF, has led a €3 million equity investment round in Ostoform.

Ostoform Exhibiting at Medica 2021

Ostoform is pleased to announce its first-time attendance at Medica 2021. MEDICA, the world’s largest medical trade fair, will…

Ostoform and Partners Receive Funding of €2.67m through Disruptive Technologies Innovation Fund

Ostoform and consortium partners, Athlone Institute of Technology, Ross Polymers (Athlone), Synecco (Galway) and Avery Dennison (Longford) are very grateful…